International Patent: METHODS AND COMPOSITIONS FOR TARGETED GENETIC INACTIVATION OF PRIMORDIAL GERM CELL (PGC) SPECIFICATION GENES FOR EFFICIENT GERMLINE ABLATION AND EXCLUSIVE DONOR CELL GERMLINE TRANSMISSION IN GENE-EDITED ANIMALS

GENEVA, July 18 -- ABS GLOBAL, INC. filed a patent application (US2026/010997) for “METHODS AND COMPOSITIONS FOR TARGETED GENETIC INACTIVATION OF PRIMORDIAL GERM CELL (PGC) SPECIFICATION GENES FOR EFFICIENT GERMLINE ABLATION AND EXCLUSIVE DONOR CELL GERMLINE TRANSMISSION IN GENE-EDITED ANIMALS”. With publication no. WO/2026/152105, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: C12N 5/0735

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....